Sandu Pharmaceuticals shareholding pattern
SANDUPHQ
34.8
0.22 (-0.63%)Last updated on 13 Feb, 2026 | 15:10 IST
BUYSELL
The current prices are delayed, login to your account for live prices
Login Summary
For Year 2025-26, Sandu Pharmaceuticals reports the following shareholding: Total Promoters at 37.79%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 0%, Domestic Institutional Investors at 0.01%, and Retail at 62.21%. This breakdown provides a quick snapshot of ownership distribution for Sandu Pharmaceuticals in 2025-26.
Sandu Pharmaceuticals FAQs
As of 02-2026, the promoter shareholding in Sandu Pharmaceuticals stands at 37.79% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Sandu Pharmaceuticals is 0% and 0.01% respectively.
The retail shareholding of the Sandu Pharmaceuticals is 62.21%.
Changes in shareholding patterns of Sandu Pharmaceuticals can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Sandu Pharmaceuticals are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Sandu Pharmaceuticals Associated Pages
- Sandu Pharmaceuticals Share Price
- Sandu Pharmaceuticals Share Price chart
- Sandu Pharmaceuticals Fundamental Analysis
- Sandu Pharmaceuticals Technical Analysis
- Sandu Pharmaceuticals Peer Comparison
- Sandu Pharmaceuticals Share Price History
- Sandu Pharmaceuticals Dividend
- Sandu Pharmaceuticals Board of Directors